On November 8, 2021 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported that senior leadership plans to present at the following conferences in November (Press release, Iovance Biotherapeutics, NOV 8, 2021, View Source [SID1234594785]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Festival of Biologics, Basel
Tuesday, November 9 at 11:10 a.m. ET
More information: View Source
Cowen 5th Annual IO Next Summit
Fireside Chat: Monday, November 15 at 3:45 p.m. ET
Live and archived webcast available at View Source
Stifel 2021 Virtual Healthcare Conference
Fireside Chat: Wednesday, November 17 at 11:20 a.m. ET
Live and archived webcast available at View Source
Cell Immunotherapies for Solid Tumors Summit
Thursday, November 18 at 10:30 a.m. ET
More information: https://solid-tumors-summit.com
Piper Sandler 33rd Annual Virtual Healthcare Conference
Fireside Chat: Pre-recorded webcast available Monday, November 22 at 10:00 a.m. ET at View Source